<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="148104">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02061787</url>
  </required_header>
  <id_info>
    <org_study_id>CPETPH</org_study_id>
    <nct_id>NCT02061787</nct_id>
  </id_info>
  <brief_title>the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension</brief_title>
  <acronym>CPETPH</acronym>
  <official_title>the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Pulmonary Vascular Disease Research Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Pulmonary Vascular Disease Research Group</source>
  <oversight_info>
    <authority>China: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The application of cardiopulmonary exercise testing in assessment outcomes of patients with
      pulmonary hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>deterioration of WHO function</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>cardiopulmonary exercise testing</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        pulmonary hypertension who may accomplish cardiopulmonary exercise testing.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pulmonary arterial hypertension;( WHO1)

          -  chronic thromboembolic pulmonary hypertension;

          -  pulmonary arterial hypertension due to other cause;

        Exclusion Criteria:

          -  massive hemoptysis;

          -  unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;

          -  recent recurrent syncope;

          -  pulmonary hypertension due to hypoxia;

          -  pulmonary hypertension due to left heart diseases.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhihong Liu, MDï¼ŒPhD</last_name>
    <role>Study Director</role>
    <affiliation>Fuwai Hospital, National Center for Cardiovascular Diseases</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhihong Liu, Doctor</last_name>
    <phone>8601088396590</phone>
    <email>zhihongliufuwai@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>center of pulmonary vascular disease, Fuwai hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiuping Ma</last_name>
      <phone>8601088396816</phone>
      <email>zhihongliufuwai@163.com</email>
    </contact>
    <investigator>
      <last_name>Zhihong Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <lastchanged_date>February 11, 2014</lastchanged_date>
  <firstreceived_date>February 11, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
